The Company’s therapeutic focus is on onology, neurology and immunology and the development of orphan drugs. Ergomed Plc manages clinical development from Phase I through to late phase programs. The Company operates in two segments: The services business and the co-development business. The clinical development services offered by the Company include study management, site management, study physician support, safety services, regulatory and quality management, clinical data management and biostatistics, and medical writing. It has planned, managed, monitored, and reported clinical trials with a range of technologies that include small molecule drugs, monoclonal antibodies, tri-functional antibodies, soluble receptors, cancer vaccines and immunotherapy, radioactive agents, and photodynamic therapies. The Company also has co-development deals with other companies.
Guildford, GB
Size (employees)
150 (est)
Ergomed is headquartered in Guildford, GB

Ergomed Office Locations

Ergomed has an office in Guildford
Guildford, GB (HQ)
26 Frederick Sanger Rd

Ergomed Data and Metrics

Ergomed Financial Metrics

Ergomed's revenue was reported to be £30.2 m in FY, 2015 which is a 43% increase from the previous period.
Numbers are in £, GBP

Revenue (FY, 2015)

30.2 m

Revenue growth (FY, 2014 - FY, 2015), %


Gross profit (FY, 2015)

8.4 m

Gross profit margin (FY, 2015), %


Net income (FY, 2015)

1.6 m

Market capitalization (26-May-2017)

82.3 m

Closing share price (26-May-2017)


Cash (31-Dec-2015)

4 m
Ergomed's current market capitalization is £82.3 m.
Numbers are in £, GBPFY, 2013FY, 2014FY, 2015


15.1 m21.2 m30.2 m

Revenue growth, %


Cost of goods sold

10.1 m15.4 m21.8 m

Gross profit

5 m5.8 m8.4 m

Gross profit Margin, %


Operating expense total

3.2 m5 m6.3 m

Pre tax profit

1.8 m777 k2.1 m

Net Income

1.5 m578 k1.6 m
Numbers are in £, GBPFY, 2013FY, 2014FY, 2015


2 m4.6 m4 m

Accounts Receivable

2.3 m4.7 m6.4 m

Current Assets

5.2 m10.9 m13.5 m


150 k547 k883 k


1.3 m10.2 m10.3 m

Total Assets

6.7 m21.7 m24.7 m

Accounts Payable

2.5 m2.7 m2.4 m

Current Liabilities

4.8 m5.8 m7.2 m

Retained Earnings

1.5 m578 k1.6 m

Total Equity

1.9 m15.3 m16.9 m

Financial Leverage

3.5 x1.4 x1.5 x
Numbers are in £, GBPFY, 2013FY, 2014FY, 2015

Cash From Operating Activities

1.4 m537 k264 k

Cash From Financing Activities

(68 k)9.1 m(1 k)

Income Taxes Paid

(232 k)(199 k)(520 k)
Numbers are in £, GBPY, 2015


201.2 k

Financial Leverage

1.5 x

Ergomed Operating Metrics

FY, 2015



Patients Studied

30 k



    Ergomed Market Value History

    Ergomed Revenue Breakdown

    Ergomed Company Life and Culture

    You may also be interested in